Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer

AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer

AstraZeneca and MSD's – known as Merck &Co in the US and Canada – Lynparza (olaparib) has been approved in the UK as part of a combination therapy for certain prostate cancer ... Ed Piper, medical and scientific affairs director, AstraZeneca UK, said

2023 PM Society Awards – winners announced

2023 PM Society Awards – winners announced 21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board. ... A Highly Commended was awarded to Purple Agency. The new Positive Pitch Award, won by AstraZeneca, was for the team’s excellent running of a recent pitch process.

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca.

HTA guidance from NICE, the SMC and the AWMSG

AstraZeneca’s Evusheld (tixagevimab and cilgavimab) has not been recommended by the National Institute for Health and Care Excellence (NICE) for the prevention of COVID-19 in vulnerable adults, the agency.

AstraZeneca announces major expansion of Canadian research footprint

AstraZeneca announces major expansion of Canadian research footprint AstraZeneca (AZ) has announced a major expansion of its research footprint in Canada with the creation of 500 highly-skilled jobs and a new Alexion rare disease research hub.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...